Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?
October 21, 2014|
In the wake of a handful of biosafety lapses at federal research facilities, the US government is temporarily halting funding for new studies aiming to give novel functions to influenza, SARS, and MERS viruses.